Literature DB >> 33520819

Prevalence of peripheral neuropathy and associated pain in patients with diabetes mellitus: Evidence from a cross-sectional study.

Harveen Baxi1, Anwar Habib2, Md Sarfaraj Hussain3, Salman Hussain4, Kiran Dubey1.   

Abstract

BACKGROUND: Diabetic peripheral neuropathy (DPN) is the most common and troublesome complication of diabetes mellitus. It affects almost half the population with diabetes and worsens quality of life of the patient. This study was aimed to determine the prevalence of peripheral neuropathy and associated pain in patients with diabetes mellitus.
METHODS: This was a cross-sectional study conducted over a period of six months. Patient's ≥ 18 years with confirmed diagnosis of diabetes mellitus were included in the study. Patients with hypothyroidism, medical illness such as cancer, liver or renal disease, cervical or lumbar spondylosis, pregnant patients with diabetes and patients receiving any treatment that might influence nerve function (e.g., cytotoxic or antiepileptic agents) were excluded from the study. DPN was diagnosed using 10 g monofilament test. The S-LANSS questionnaire was used to assess the associated painful symptoms. Association was calculated using chi-square test. A p- value of ≤0.05 was considered statistically significant. All the statistical analysis was performed using SPSS v22. RESULT: The overall prevalence of DPN was found to be 28.85% from which 88% patients were found to have painful symptoms. A significant association of DPN was observed with the duration of diabetes (p = 0.004), poor glycaemic control (p = 0.03) and other diabetic complications such as nephropathy (p = 0.002). No association of neuropathy was found with retinopathy and hypertension. Duration of diabetes (>15 years), and HbA1c (>9%) was found to be positively associated the painful DPN.
CONCLUSION: The current study found a high prevalence of DPN and it was found to be significantly associated with duration of diabetes, poor glycaemic control and nephropathy. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  DPN; Diabetes complications; Diabetic neuropathy; India; T2DM

Year:  2020        PMID: 33520819      PMCID: PMC7843660          DOI: 10.1007/s40200-020-00597-y

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  40 in total

1.  World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects.

Authors: 
Journal:  Bull World Health Organ       Date:  2003-07-02       Impact factor: 9.408

Review 2.  Alpha lipoic acid: a new treatment for neuropathic pain in patients with diabetes?

Authors:  G S Mijnhout; A Alkhalaf; N Kleefstra; H J G Bilo
Journal:  Neth J Med       Date:  2010-04       Impact factor: 1.422

3.  Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period?

Authors:  Anne L Carrington; Jonathan E Shaw; Carine H M Van Schie; Caroline A Abbott; Loretta Vileikyte; Andrew J M Boulton
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

4.  Pilot Study of Exercise Therapy on Painful Diabetic Peripheral Neuropathy.

Authors:  Min Yoo; Linda J D'Silva; Katherine Martin; Neena K Sharma; Mamatha Pasnoor; Joseph W LeMaster; Patricia M Kluding
Journal:  Pain Med       Date:  2015-03-20       Impact factor: 3.750

5.  Insensate foot of diabetic foot ulcer can have underlying silent neuropathic pain.

Authors:  Y M Yunus; S M Rajbhandari
Journal:  Int Wound J       Date:  2011-05-04       Impact factor: 3.315

Review 6.  Diabetic neuropathy.

Authors:  Aaron I Vinik; Marie-Laure Nevoret; Carolina Casellini; Henri Parson
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12       Impact factor: 4.741

Review 7.  Mechanisms and pharmacology of diabetic neuropathy - experimental and clinical studies.

Authors:  Magdalena Zychowska; Ewelina Rojewska; Barbara Przewlocka; Joanna Mika
Journal:  Pharmacol Rep       Date:  2013       Impact factor: 3.024

8.  Chronic pain in type 2 diabetic patients: a cross-sectional study in primary care setting.

Authors:  Orly Liberman; Roni Peleg; Pesach Shvartzman
Journal:  Eur J Gen Pract       Date:  2014-03-19       Impact factor: 1.904

9.  Diabetic foot screening: study of a 3000 times cheaper instrument.

Authors:  Maria Candida Ribeiro Parisi; Daniel Giannella; Tulio Diniz Fernandes; Karla Freire Rezende; Marcia Nery
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  Diabetic Peripheral Neuropathy and its Determinants among Patients Attending a Tertiary Health Care Centre in Mangalore, India.

Authors:  Monisha D'Souza; Vaman Kulkarni; Unnikrishnan Bhaskaran; Humam Ahmed; Hegde Naimish; Anjali Prakash; Tabreez S; Bhanu Dahiya; Rekha Thapar; Prasanna Mithra; Nithin Kumar; Ramesh Holla; Darshan Bb; Avinash Kumar
Journal:  J Public Health Res       Date:  2015-07-30
View more
  2 in total

Review 1.  An Insight into Potential Pharmacotherapeutic Agents for Painful Diabetic Neuropathy.

Authors:  Zunaira Qureshi; Murtaza Najabat Ali; Minahil Khalid
Journal:  J Diabetes Res       Date:  2022-01-27       Impact factor: 4.011

2.  Correlation between Acylcarnitine and Peripheral Neuropathy in Type 2 Diabetes Mellitus.

Authors:  Zhenni An; Danmeng Zheng; Dongzhuo Wei; Dingwen Jiang; Xuejiao Xing; Chang Liu
Journal:  J Diabetes Res       Date:  2022-02-17       Impact factor: 4.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.